Plasma Adsorption in Patients With Confirmed COVID-19
Public ClinicalTrials.gov record NCT04358003. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Plasma Adsorption in Patients With Confirmed COVID-19 Infection
Study identification
- NCT ID
- NCT04358003
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Marker Therapeutics AG
- Industry
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol) Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 19, 2020
- Primary completion
- Nov 25, 2021
- Completion
- Mar 31, 2022
- Last update posted
- Apr 10, 2022
2020 – 2022
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas for Medical Sciences (UAMS) | Little Rock | Arkansas | 72205 | — |
| UNM Health Science Center | Albuquerque | New Mexico | 87131 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Reading Hospital | West Reading | Pennsylvania | 19611 | — |
| UT Southwestern/Clements Hospital | Dallas | Texas | 75390 | — |
| UTMB | Galveston | Texas | 77550 | — |
| Inova Fairfax Medical Campus | Falls Church | Virginia | 22042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04358003, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 10, 2022 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04358003 live on ClinicalTrials.gov.